Sun Pharmaceutical Industries Limited
SUNPHARMA
Helyezés a részvények között
#525
Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical... Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical enterprise, is dedicated to the research, development, production, and marketing of both proprietary and unbranded medicinal formulations, alongside active pharmaceutical ingredients (APIs), for distribution across India and international markets. Its extensive product range encompasses treatments for numerous therapeutic fields, including central nervous system disorders, dermatological conditions, cardiovascular diseases, oncology, ophthalmic care, neuropsychiatry, gastrointestinal issues, infectious diseases, diabetes management, pain relief, nutritional supplements, respiratory ailments, gynaecology, urology, orthopaedics, nephrology, and dental health, among others. The company additionally provides APIs crucial for the creation of anti-cancer drugs, peptides, steroids, sex hormones, and controlled substances. Its generic medications are available in various forms, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquid preparations. Furthermore, Sun Pharma develops specialized medications and a variety of over-the-counter health products. The company was established in 1983 and operates from its headquarters in Mumbai, India.
Részvényárfolyam
$19.24
Piaci kapitalizáció
$46.15B
Változás (1 nap)
-0.97%
Változás (1 év)
0.84%
Ország
IN
Kereskedés Sun Pharmaceutical Industries Limited (SUNPHARMA)
Kategória
Healthcare
EPS Sun Pharmaceutical Industries Limited (SUNPHARMA) részvényre
EPS June 2026 dátummal, TTM: $0.56
Sun Pharmaceutical Industries Limited legfrissebb pénzügyi jelentései és részvényára alapján a vállalat jelenlegi EPS mutatója (TTM) $0.56. 2024 végén a vállalat EPS mutatója $0.48 volt, növekedés a 2023 év EPS értékéhez, amely $0.43 volt.
Sun Pharmaceutical Industries Limited EPS története 2004 és 2026 között
EPS minden év végén
| Év | EPS | Változtassa meg |
|---|---|---|
| 2026 (TTM) | $0.56 | 4.96% |
| 2025 | $0.53 | 11.41% |
| 2024 | $0.48 | 11.35% |
| 2023 | $0.43 | 139.18% |
| 2022 | $0.18 | 8.71% |
| 2021 | $0.17 | -20.64% |
| 2020 | $0.21 | 30.19% |
| 2019 | $0.16 | 15.61% |
| 2018 | $0.14 | -69.05% |
| 2017 | $0.45 | 56.75% |
| 2016 | $0.29 | -5.81% |
| 2015 | $0.30 | 19.44% |
| 2014 | $0.25 | -4.30% |
| 2013 | $0.27 | 4.58% |
| 2012 | $0.25 | 29.09% |
| 2011 | $0.20 | 35.66% |
| 2010 | $0.14 | -16.31% |
| 2009 | $0.17 | -7.39% |
| 2008 | $0.19 | 94.07% |
| 2007 | $0.10 | 38.62% |
| 2006 | $0.07 | 41.63% |
| 2005 | $0.05 | 19.51% |
| 2004 | $0.04 | 0.00% |
EPS hasonló cégek vagy versenytársak esetén
| Vállalat | EPS | EPS különbség | Ország |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| - | - |
CH
|
